Text Size

Elevated Triglyceride Levels and Later Type 2 Diabetes

This study has been completed.
Sponsor:
Information provided by:
University of Tromso
ClinicalTrials.gov Identifier:
NCT01182935
First received: August 11, 2010
Last updated: July 19, 2011
Last verified: July 2011
History of Changes
  Purpose

Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes


Condition
Type 2 Diabetes

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Elevated Triglyceride Levels and Later Type 2 Diabetes

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Tromso:

Primary Outcome Measures:
  • Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT) [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The relation between serum 25(OH)D levels and blood glucose levels at OGTT [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

serum


Enrollment: 3509
Study Start Date: April 2010
Study Completion Date: November 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
participants in the 4th Tromsø study

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels

Criteria

Inclusion Criteria:

  • participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

Exclusion Criteria:

  • type 2 diabetes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01182935

Locations
Norway
Univesity of Tromsø
Tromsø, Norway, 9037
Sponsors and Collaborators
University of Tromso
Investigators
Principal Investigator: rolf jorde, md University of Tromso
  More Information

No publications provided

Responsible Party: Rolf Jorde, Univesity of Tromsø
ClinicalTrials.gov Identifier: NCT01182935     History of Changes
Other Study ID Numbers: UIT-ENDO-2010-3
Study First Received: August 11, 2010
Last Updated: July 19, 2011
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by University of Tromso:
vitamin D
triglycerides
type 2 diabetes

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hypertriglyceridemia
Glucose Metabolism Disorders
Metabolic Diseases
 Endocrine System Diseases
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on May 21, 2013